BTK Inhibitors in Practice

CME

Targeted Therapeutics in CLL and MCL: Applying Emerging BTK Inhibitor Therapy Data to Practice

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: July 18, 2023

Expiration: July 17, 2024

Toby A Eyre
Toby A Eyre, MBChB, MD

Activity

Progress
1
Course Completed